However, men with high-risk localized PCa [as defined by the parameters including serum prostate-specific antigen (PSA) levels, clinical stage, and histological grade] have a significantly higher possibility of biochemical relapse than the control groups [3,4]. This evidence concerns the gene KLK3 and posterior cortical atrophy.